Injection, dolasetron mesylate, 10 mg
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
ANZEMET is an Oncology-Anti-Emetic drug manufactured by Sanofi and administered via the Intravenous route of administration. The J Code: J1260 is aligned to the drug ANZEMET.
January 1, 1999
January 1, 2000